TCR-based therapy for multiple myeloma and other B-cell malignancies targeting intracellular transcription factor BOB1

Autor: Jahn, Lorenz, Hombrink, Pleun, Hagedoorn, Renate S., Kester, Michel G.D., van der Steen, Dirk M., Rodriguez, Tania, Pentcheva-Hoang, Tsvetelina, de Ru, Arnoud H., Schoonakker, Marjolein P., Meeuwsen, Miranda H., Griffioen, Marieke, van Veelen, Peter A., Falkenburg, J.H.Frederik, Heemskerk, Mirjam H.M.
Zdroj: In Blood 9 March 2017 129(10):1284-1295
Databáze: ScienceDirect